Exploring the Role of Circulating miR-134 in Breast Cancer Recurrence
ISEF · 2019 Biomedical and Health Sciences
Overview
MicroRNAs (miRNAs) are short sequences of RNA (about 22 nucleotides) that are involved in the regulation of gene expression. My previous study has identified the serum miR-134 as a new biomarker to predict breast cancer recurrence after primary treatment. To further study the function of miR-134 in breast cancer progression, I transfected miR-134 into breast cancer and macrophage cells. I found that overexpression of miR-134 had no effect on tumor cell proliferation but induced macrophage phenotypic changes. Interestingly, the conditioned medium from miR-134 overexpressed macrophage cells promoted the growth of tumor cells. My results suggested that circulating miR-134 may promote tumor progression and recurrence by potentially mediating the interaction between tumor cells and immune cells.
Competition history
- ISEF 2019
Resources
Related projects
ISEF · 2017
The Development of Specific Colon Cancer microRNA Profiles for Early and Accurate Diagnosis
ISEF · 2018
Blocking Multidrug Resistance in Cancer Cells with MicroRNA Mimics
ISEF · 2022
Investigation of CD47 Dependent miRNAs as Early Cancer Detection Biomarker Using Liquid Biopsy Database
ISEF · 2016
An Analysis of Ectopic Expression of MicroRNAs Targeting the Androgen Receptor on the Viability of Prostate Cancer Cells
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair